Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Single Center Exploratory Study to Evaluate Safety and Efficacy of NK520 for Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06541444 is registered in ClinicalTrials.gov with Base Therapeutics (Shanghai) Co., Ltd. as lead sponsor.

NCT NCT06541444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06541444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Single Center Exploratory Study to Evaluate Safety and Efficacy of NK520 for Patients With Relapsed/Refractory Acute Myeloid Leukemia
Lead sponsor
Base Therapeutics (Shanghai) Co., Ltd.
Phase
Phase 1
Overall status
Terminated
Start date
July 1, 2024
Completion date
June 1, 2025
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory acute myeloid leukemia